The relationship between metabolic dysfunction‐associated fatty liver disease and low muscle mass in an asymptomatic Korean population-Reference-Cited by-同舟云学术

The relationship between metabolic dysfunction‐associated fatty liver disease and low muscle mass in an asymptomatic Korean population

Published:2022-10-12 Issue:6 Volume:13 Page:2953-2960
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:J cachexia sarcopenia muscle

Author:

Seo Ji Yeon¹,Cho Eun Ju²,Kim Min Joo³,Kwak Min‐Sun¹,Yang Jong In¹,Chung Su Jin¹,Yim Jeong Yoon¹,Yoon Ji Won³,Chung Goh Eun¹^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology, Internal Medicine and Healthcare Research Institute Seoul National University Hospital Healthcare System Gangnam Center Seoul South Korea

2. Department of Gastroenterology and Hepatology, Internal Medicine and Liver Research Institute Seoul National University Hospital Seoul South Korea

3. Department of Endocrinology, Internal Medicine and Healthcare Research Institute Seoul National University Hospital Healthcare System Gangnam Center Seoul South Korea

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcsm.13099

Reference40 articles.

1. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

2. MAFLD: Renovation of clinical practice and disease awareness of fatty liver

3. Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta‐analysis: Focusing on the non‐overlap groups

4. Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name

5. The NAFLD‐MAFLD debate: Is there a Consensus‐on‐Consensus methodology?

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of muscle mass, grip strength and fat-to-muscle ratio and metabolic dysfunction-associated steatotic liver disease in a middle-to-elderly aged population;Annals of Medicine;2024-08-12

2. Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography;Journal of Cachexia, Sarcopenia and Muscle;2024-07-16

3. Assessment of the appropriate cutoff points for anthropometric indices and their relationship with cardio-metabolic indices to predict the risk of metabolic associated fatty liver disease;BMC Endocrine Disorders;2024-06-04

4. Metabolic dysfunction-associated fatty liver disease and low muscle strength: A comment;World Journal of Gastroenterology;2024-05-07

5. Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank;Calcified Tissue International;2024-04-28